MICHAEL VOLK to Pyridines
This is a "connection" page, showing publications MICHAEL VOLK has written about Pyridines.
Connection Strength
0.052
-
Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety. Hepatology. 2010 Jan; 51(1):165-73.
Score: 0.052